Author's Manuscript As Accepted for Publishing After the Review Process but Prior to Final Layout and Copyediting) of the Article: Laakso, M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Open Access Policies of Leading Medical Journals: a Cross-Sectional Study
Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-028655 on 20 June 2019. Downloaded from Open access policies of leading medical journals: a cross-sectional study Tim S Ellison, 1 Tim Koder, 2 Laura Schmidt, 2 Amy Williams, 1 Christopher C Winchester 2 To cite: Ellison TS, Koder T, ABSTRACT Strengths and limitations of this study Schmidt L, et al. Open Objectives Academical and not-for-profit research access policies of leading funders are increasingly requiring that the research they ► This manuscript includes a cross-sectional analysis medical journals: a cross- fund must be published open access, with some insisting sectional study. BMJ Open of open access policies of medical journals with a on publishing with a Creative Commons Attribution (CC 2019;9:e028655. doi:10.1136/ high impact factor, including society-owned jour- BY) licence to allow the broadest possible use. We aimed bmjopen-2018-028655 nals, from multiple publishers. to clarify the open access variants provided by leading ► The open access policies of all journals analysed ► Prepublication history medical journals and record the availability of the CC BY were clarified, and confirmation of our findings and additional material for licence for commercially funded research. was received by email from 97% of the contacted this paper are available Methods We identified medical journals with a 2015 online. To view these files, journals. impact factor of ≥15.0 on 24 May 2017, then excluded please visit the journal online ► Open access policies of the journals and publishers from the analysis journals that only publish review articles. -
The International Journal of Biochemistry & Cell Biology
THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.5 ISSN: 1357-2725 DESCRIPTION . IJBCB publishes original research articles, invited reviews and in-focus articles in all areas of cell and molecular biology and biomedical research. Topics of interest include, but are not limited to: Mechanistic studies of cells, cell organelles, sub- cellular molecular pathways and metabolism Novel insights into disease pathogenesis Nanotechnology with implication to biological and medical processes Genomics and bioinformatics IMPACT FACTOR . 2020: 5.085 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Elsevier BIOBASE Current Contents - Life Sciences Chemical Abstracts EMBiology BIOSIS Citation Index Embase Current Contents Current Contents Current Contents PubMed/Medline Research Alert Scopus ISI Science Citation Index EDITORIAL BOARD . Editor-in-Chief Maddy Parsons, King's College London, London, United Kingdom Cell adhesion; Cell signalling; Cell migration; Cytoskeleton; Microscopy; Focal adhesion; Integrins; Cadherins; Epithelial cells; Cancer cell invasion; Extracellular matrix; 3D matrices; Microscopy AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/biocel 1 Senior Editors Joanna Kargul, University of Warsaw, Warsaw, Poland Areas of Expertise: Associate Editors Tin-Lap Lee, The Chinese University of Hong Kong, Shatin, New Territories, Hong -
Open Access Policies of Leading Medical Journals: a Cross- Sectional Study
bioRxiv preprint doi: https://doi.org/10.1101/250613; this version posted December 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Preprint title: Open access policies of leading medical journals: a cross- sectional study Authors: Tim S Ellison1 (https://orcid.org/0000-0003-0307-725X), Tim Koder2 (https://orcid.org/0000-0001-6152-7365), Laura Schmidt2 (https://orcid.org/0000-0001-6117-781X), Amy Williams1 (https://orcid.org/0000-0002-9354-6402), Christopher C Winchester2 (https://orcid.org/0000-0003-3267-3990) 1PharmaGenesis London, London, UK 2Oxford PharmaGenesis, Oxford, UK This draft manuscript is the second version of a preprint that will be submitted to a peer-reviewed journal in due course, with the aim of publishing it with a CC BY licence. The work was presented as a poster at the European Meeting of ISMPP on 23 January 2018. Correspondence to: Dr Tim Ellison Address: PharmaGenesis London, 9 Whitehall, 4th Floor, London, SW1A 2DD Email: [email protected] Phone: +44 203 675 7065 Keywords: article processing charges, CC BY, Creative Commons, funding, open access, pharmaceutical, industry, commercial, disclosure Word count (excluding abstract, references and figures and tables): 2827 Abstract word count: 302 Figures and tables: 6 (excluding 2 supplemental tables) References: 45 1 bioRxiv preprint doi: https://doi.org/10.1101/250613; this version posted December 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. -
The International Journal of Biochemistry & Cell Biology
THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.5 ISSN: 1357-2725 DESCRIPTION . IJBCB publishes original research articles, invited reviews and in-focus articles in all areas of cell and molecular biology and biomedical research. Topics of interest include, but are not limited to: Mechanistic studies of cells, cell organelles, sub- cellular molecular pathways and metabolism Novel insights into disease pathogenesis Nanotechnology with implication to biological and medical processes Genomics and bioinformatics IMPACT FACTOR . 2020: 5.085 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Elsevier BIOBASE Current Contents - Life Sciences Chemical Abstracts EMBiology BIOSIS Citation Index Embase Current Contents Current Contents Current Contents PubMed/Medline Research Alert Scopus ISI Science Citation Index EDITORIAL BOARD . Editor-in-Chief Maddy Parsons, King's College London, London, United Kingdom Cell adhesion; Cell signalling; Cell migration; Cytoskeleton; Microscopy; Focal adhesion; Integrins; Cadherins; Epithelial cells; Cancer cell invasion; Extracellular matrix; 3D matrices; Microscopy AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/biocel 1 Senior Editors Joanna Kargul, University of Warsaw, Warsaw, Poland Areas of Expertise: Associate Editors Tin-Lap Lee, The Chinese University of Hong Kong, Shatin, New Territories, Hong -
Who's Afraid of Peer Review?
on October 5, 2013 www.sciencemag.org Who’s Afraid of Peer Review? A spoof paper concocted by Science reveals little or no scrutiny at many open-access journals Downloaded from On 4 July, good news arrived in the inbox of Ocorrafoo Cobange, a subscriptions. Most of the players are murky. The identity and biologist at the Wassee Institute of Medicine in Asmara. It was the offi - location of the journals’ editors, as well as the fi nancial work- cial letter of acceptance for a paper he had submitted 2 months earlier ings of their publishers, are often purposefully obscured. But to the Journal of Natural Pharmaceuticals, describing the anticancer Science’s investigation casts a powerful light. Internet Protocol properties of a chemical that Cobange had extracted from a lichen. (IP) address traces within the raw headers of e-mails sent by In fact, it should have been promptly rejected. Any reviewer with journal editors betray their locations. Invoices for publication fees more than a high-school knowledge of chemistry and the ability to reveal a network of bank accounts based mostly in the develop- understand a basic data plot should have spotted the paper’s short- ing world. And the acceptances and rejections of the paper provide comings immediately. Its experiments are so hopelessly fl awed that the fi rst global snapshot of peer review across the open-access the results are meaningless. scientifi c enterprise. I know because I wrote the paper. Ocorrafoo Cobange does One might have expected credible peer review at the Journal not exist, nor does the Wassee Institute of Medicine.